Invivyd (IVVD) Net Cash Flow (2021 - 2025)
Invivyd (IVVD) reported Net Cash Flow of $141.7 million for Q4 2025, up 477.64% on a YoY basis from $24.5 million in Q4 2024, and up 183.09% quarter-over-quarter from $50.1 million in Q3 2025.
Invivyd (IVVD) Net Cash Flow (2021 - 2025) Analysis & Trends
Invivyd has reported Net Cash Flow for 5 years, with the latest figure at $141.7 million in Q4 2025.
- For the quarter ending Q4 2025, Net Cash Flow rose 477.64% year-over-year to $141.7 million; the trailing twelve-month figure through Dec 2025 stood at $157.3 million (up 219.83% YoY), and the FY2025 full-year result was $157.3 million, up 219.83% from the prior year.
- Net Cash Flow for Q4 2025 stood at $141.7 million, up from $50.1 million in the prior quarter.
- The five-year high for Net Cash Flow was $301.3 million in Q2 2021, with the low at -$196.7 million in Q3 2022.
- Historically, Net Cash Flow has averaged $5.6 million across 5 years, with a median of -$10.6 million in 2022.
- Annual changes were most pronounced in 2024 — Net Cash Flow slumped 817.08% — and 2025, when it surged 477.64%.
- Invivyd's Net Cash Flow stood at $64.0 million in 2021, then tumbled by 390.95% to -$186.1 million in 2022, then soared by 110.11% to $18.8 million in 2023, then sank by 299.42% to -$37.5 million in 2024, then surged by 477.64% to $141.7 million in 2025.
- The last three Net Cash Flow figures came in at $141.7 million (Q4 2025), $50.1 million (Q3 2025), and -$13.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | Invivyd | 168.41 Mn | -58.28 Mn | - | 141.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 141.72 Mn |
| Dec 31, 2025 | 141.72 Mn |
| Sep 30, 2025 | 50.06 Mn |
| Sep 30, 2025 | 50.06 Mn |
| Jun 30, 2025 | -13.18 Mn |
| Jun 30, 2025 | -13.18 Mn |
| Mar 31, 2025 | -21.26 Mn |
| Mar 31, 2025 | -21.26 Mn |
| Dec 31, 2024 | -37.53 Mn |
| Dec 31, 2024 | -37.53 Mn |
| Sep 30, 2024 | -41.01 Mn |
| Sep 30, 2024 | -41.01 Mn |
| Jun 30, 2024 | -41.51 Mn |
| Jun 30, 2024 | -41.51 Mn |
| Mar 31, 2024 | -11.25 Mn |
| Mar 31, 2024 | -11.25 Mn |
| Dec 31, 2023 | 18.82 Mn |
| Dec 31, 2023 | 18.82 Mn |
| Sep 30, 2023 | 59.88 Mn |
| Sep 30, 2023 | 59.88 Mn |